Landos Biopharma
Stock Forecast, Prediction & Price Target
Landos Biopharma Financial Estimates
Landos Biopharma Revenue Estimates
Landos Biopharma EBITDA Estimates
Landos Biopharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $18M N/A | $0 -100% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $1M Low: $1M High: $1M avg. 0% | Avg: $600K Low: $600K High: $600K avg. -40% | Avg: $18.2M Low: $18.2M High: $18.2M avg. 2933.33% |
Net Income
% change YoY
| $-38.22M N/A | $-37.99M 0.61% | $-21.93M 42.26% | Avg: $-45M Low: $-12.99M High: $-12.99M avg. -105.15% | Avg: $-87.4M Low: $-7.46M High: $-7.46M avg. -94.22% | Avg: $-6.40M Low: $-6.40M High: $-6.40M avg. 92.67% | Avg: $-6.21M Low: $-6.21M High: $-6.21M avg. 2.94% |
EBITDA
% change YoY
| $-38.81M N/A | $-40.56M -4.49% | $-22.72M 43.96% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $600K Low: $600K High: $600K avg. 0% | Avg: $360K Low: $360K High: $360K avg. -40% | Avg: $10.92M Low: $10.92M High: $10.92M avg. 2933.33% |
EPS
% change YoY
| -$9.5 N/A | -$9.44 0.63% | -$3.5 62.92% | Avg: -$2.07 Low: -$2.07 High: -$2.07 avg. 40.85% | Avg: -$1.19 Low: -$1.19 High: -$1.19 avg. 42.51% | Avg: -$1.02 Low: -$1.02 High: -$1.02 avg. 14.28% | Avg: -$0.99 Low: -$0.99 High: -$0.99 avg. 2.94% |
Operating Expenses
% change YoY
| $56.81M N/A | $40.56M -28.60% | $22.72M -43.96% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $969.46K Low: $969.46K High: $969.46K avg. 0% | Avg: $581.68K Low: $581.68K High: $581.68K avg. -39.99% | Avg: $17.64M Low: $17.64M High: $17.64M avg. 2933.33% |
FAQ
What is Landos Biopharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -25.93% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -12.99M, average is -45M and high is -12.99M.
What is Landos Biopharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 723.33% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Landos Biopharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 25.14% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.07, average is -$2.07 and high is $-2.07.